FR2692787A1 - Disinfectant compsn. contg. amine and/or aldehyde - contg. pyrrolidone cpd., to prevent coagulation in presence of incompatible cpd. - Google Patents

Disinfectant compsn. contg. amine and/or aldehyde - contg. pyrrolidone cpd., to prevent coagulation in presence of incompatible cpd. Download PDF

Info

Publication number
FR2692787A1
FR2692787A1 FR9207714A FR9207714A FR2692787A1 FR 2692787 A1 FR2692787 A1 FR 2692787A1 FR 9207714 A FR9207714 A FR 9207714A FR 9207714 A FR9207714 A FR 9207714A FR 2692787 A1 FR2692787 A1 FR 2692787A1
Authority
FR
France
Prior art keywords
sep
amine
pyrrolidone
derivatives
contg
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR9207714A
Other languages
French (fr)
Other versions
FR2692787B1 (en
Inventor
Salkind Andre
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to FR9207714A priority Critical patent/FR2692787B1/en
Publication of FR2692787A1 publication Critical patent/FR2692787A1/en
Application granted granted Critical
Publication of FR2692787B1 publication Critical patent/FR2692787B1/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N33/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic nitrogen compounds
    • A01N33/02—Amines; Quaternary ammonium compounds
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N35/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical
    • A01N35/02—Biocides, pest repellants or attractants, or plant growth regulators containing organic compounds containing a carbon atom having two bonds to hetero atoms with at the most one bond to halogen, e.g. aldehyde radical containing aliphatically bound aldehyde or keto groups, or thio analogues thereof; Derivatives thereof, e.g. acetals

Abstract

Compsn. contg. amine derivs. (I) or aldehyde derivs. (II) which can be contacted with incorporated chemicals without coagulation to form an adherent agglomerated mass, contains at least 0.001% of a pyrrolidone deriv. (III), pref. polyvinyl pyrrolidone (PVP). (I) is a prim. sec. and/or tert amine, alkyl and/or aryl-amine, polyamine, alkylaminoglycine and/or tert. alkylamine, esp. diaminopropyl-laurylamine. (II) is formaldehyde or glutaraldehyde. PVP as (III) is used at 0.001% up to the max. concn. allowing formulation as pellets, cachets or powder. The compsn. are in liq. gel, capsule, pellet or powder form. USE/ADVANTAGE - The compsns. are esp. disinfectants (claimed) e.g. for cleaning and disinfection of surgical devices such as endoscopes. (I) and (II) both have disinfectant action. (III) esp. prevent formation of a rubber mass from (I) and (II) which can block tubes, pumps or devices (e.g. endoscopes) being treated.

Description

Fabrication et formulation de produits dérivés d'amines primaires, secondaires ou tertiaires, dérivés alkyliques et/ou aryliques et/ou polyamines et/ou alkylaminoglycines et/ou alkylamines tertiaires pouvant être mis en contact avec des matières chimiques incompatibles sans former d'agglomérats ni d'adhérence.Manufacture and formulation of products derived from primary, secondary or tertiary amines, alkyl and / or aryl derivatives and / or polyamines and / or alkylaminoglycines and / or tertiary alkyl amines which can be brought into contact with incompatible chemical materials without forming agglomerates or adhesion.

Composition de dérivés aldéhydiques pouvant être mis en contact avec des dérivés d'amines primaires et/ou secondaires et/ou tertiaires et/ou des dérivés alkyliques et/ou aryliques et/ou polyamines et/ou alkylaminoglycines et/ou alkylamines tertiaires sans former d'agglomérats ni d'adhérence et leurs applications.Composition of aldehyde derivatives which can be contacted with primary and / or secondary and / or tertiary amine derivatives and / or alkyl and / or aryl derivatives and / or polyamines and / or alkylaminoglycines and / or tertiary alkyl amines without forming agglomerates and adhesion and their applications.

La présente invention a pour objet d'éviter les inconvénients dts à l'incompatibilité de certains dérivés aminés au contact d'autres composés chimiques et d'une manière non exhaustive, au contact de dérivés aldéhydiques.The present invention aims to avoid the disadvantages of the incompatibility of certain amino derivatives in contact with other chemical compounds and in a non-exhaustive manner, in contact with aldehyde derivatives.

La présente invention a pour objet d'éviter les inconvénients dus à l'incompatibilité de certains dérivés aldéhydiques au contact de composés chimiques incompatibles dont les dérivés aminés et d'une manière non exhaustive, les dérivés d'amines primaires et/ou secondaires et/ou tertiaires et/ou alkyliques et/ou aryliques et/ou polyamines et/ou alkylaminoglycines et/ou alkylamines tertiaires sans former d'agglomérats ni d'adhérence.The present invention aims to avoid the disadvantages due to the incompatibility of certain aldehyde derivatives in contact with incompatible chemical compounds including amino derivatives and in a non-exhaustive manner, derivatives of primary amines and / or secondary and / or or tertiary and / or alkyl and / or aryl and / or polyamines and / or alkylaminoglycines and / or tertiary alkyl amines without forming agglomerates or adhesion.

L'incompatibilité des dérivés aminés tels que les dérivés d'amines primaires et/ou secondaires et/ou tertiaires et/ou les dérivés alkyliques et/ou aryliques et/ou polyamines et/ou alkylaminoglycine et/ou alkyle amine tertiaire ne peuvent être mis en contact avec des matières chimiques incompatibles sans former d'agglomérats ni d'adhérence, par exemple et d'une manière non exhaustive, connus sous les appellations commerciales LONZABAG 4 et LONZABAC 1Z,
LONZABAC 12 décrit sous la formule générale C8 H41 N3 par la SOCIETE
LONZA FRANCE, filiale de LONZA S.A. - CH4 OO BALE SUISSE - empêchent l'emploi de tels produits tel quel ou en formulation en présence de matière incompatible qui réagissent immédiatement et forment des agglomérats et adhérences.The incompatibility of the amine derivatives such as the primary and / or secondary and / or tertiary amine derivatives and / or the alkyl and / or aryl and / or polyamine and / or alkylaminoglycine and / or tertiary alkyl amine derivatives can not be used. in contact with incompatible chemical materials without forming agglomerates or adhesion, for example and in a non-exhaustive manner, known under the trade names LONZABAG 4 and LONZABAC 1Z,
LONZABAC 12 described under the general formula C8 H41 N3 by the COMPANY
LONZA FRANCE, a subsidiary of LONZA SA - CH4 OO BALE SUISSE - prevents the use of such products as such or in formulation in the presence of incompatible material that react immediately and form agglomerates and adhesions.

La présente invention est un perfectionnement au procédé de fabrication, d'utilisation de préparation et de formulation de dérivés aminés tels que les dérivés d'amines primaires et/ou secondaires et/ou tertiaires et/ou les dérivés alkyliques et/ou aryliques et/ou polyamines et/ou alkylaminoglycines et/ou alkylamines tertiaires qui ne peuvent être mis en contact avec des matières chimiques incompatibles sans former d'agglomérats ni d'adhérence et en particulier, à des préparations, å titre non exhaustif, de dérivés aminés LONZABC 4, LONZABAC 12 qui sont connus pour leur utilisation dans les domaines de l'hygiène et la désinfection.The present invention is an improvement in the process for the manufacture, use of preparation and formulation of amine derivatives such as primary and / or secondary and / or tertiary amine derivatives and / or alkyl and / or aryl derivatives and / or polyamines and / or alkylaminoglycines and / or tertiary alkylamines which can not be brought into contact with incompatible chemical materials without forming agglomerates and adhesion and in particular, to non-exhaustive preparations of amino derivatives LONZABC 4 , LONZABAC 12 which are known for their use in the fields of hygiene and disinfection.

De tels produits actifs sont peu ou pas utilisables et non envisageables dans le cas oû ils seraient mis en contact avec des matières incompatibles et en particulier, des dérivés aldéhydiques par exemple, et d'une manière non exhaustive, en présence de glutaraldéhyde car il y aurait immédiatement formation d'un agglomérat épais, å consistance caoutchouteuse, relativement adhérent. Such active products are little or not usable and not conceivable in the case where they are brought into contact with incompatible materials and in particular, aldehyde derivatives for example, and in a non-exhaustive manner, in the presence of glutaraldehyde because there is would immediately have formed a thick agglomerate, with a rubbery consistency, relatively adherent.

En effet, une simple démonstration permet de visualiser la prise en masse. Dans le cas d'une préparation en cuve, d'un écoulement ou d'une aspiration par des tuyaux ou des pompes qui contiendraient quelques particules d'une matière incompatible, on constaterait une réaction qui provoquerait une prise en masse et une obturation des tuyauteries.Indeed, a simple demonstration allows to visualize the en masse. In the case of a tank preparation, a flow or a suction by pipes or pumps which contain a few particles of an incompatible material, there would be a reaction which would cause a caking and plugging of the pipes. .

Plus particulièrement, dans le domaine du nettoyage et de la désinfection du matériel chirurgical, par exemple et plus particulièrement, du nettoyage et de la désinfection des endoscopes, appareils d'exploration utilisés dans le domaine médical, munis de micro-conduits nécessaires aux prélèvements par aspiration pour biopsie, l'utilisation de produits dérivés tels que des dérivés d'amines primaires et/ou secondaires etZou tertiaires etfou dérivés alkyliques et/ou aryliques et/ou- polyamines et/ou alkylamminoglycines et/ou alkylamines tertiaires provoquerait au contact de particules tels que des dérivés aldéhydiques en présence ou non de protéines, des prises en masse, des adhérences formant ainsi des bouchons rendant le matériel complètement inapte à l'usage prévu.More particularly, in the field of cleaning and disinfection of surgical equipment, for example and more particularly, the cleaning and disinfection of endoscopes, exploration devices used in the medical field, provided with micro-ducts necessary for sampling by aspiration for biopsy, the use of derivatives such as derivatives of primary and / or secondary and tertiary amines and / or alkyl and / or aryl derivatives and / or polyamines and / or alkylamminoglycines and / or tertiary alkylamines would cause on contact with particles such as aldehyde derivatives in the presence or absence of proteins, caking, adhesions thus forming plugs making the material completely unsuitable for the intended use.

L'utilisation de dérivés aldéhydiques, plus particulièrement de glutaraldéhyde et d'une manière non exhaustive pour la désinfection du matériel d'endoscopie qui serait mis en contact avec des particules de dérivés aminés tels que dérivés d'amines primaires et/ou secondaires et/ou tertiaires et/ou des dérivés alkyliques et/ou aryliques et/ou polyamines et/ou alkylaminoglycines et/ou alkylamines tertiaires en présence ou non de protéines formeraient immédiatement des bouchons rendant le matériel complètement inapte à l'usage prévu.The use of aldehyde derivatives, more particularly of glutaraldehyde and in a non-exhaustive manner for the disinfection of the endoscopic equipment which would be put in contact with particles of amine derivatives such as derivatives of primary and / or secondary amines and / or tertiary and / or alkyl and / or aryl derivatives and / or polyamines and / or alkylaminoglycines and / or tertiary alkylamines in the presence or absence of proteins would immediately form plugs making the material completely unsuitable for the intended use.

D'une part, la présente invention consiste dans la procédure de formulation de produits dérivés aminés tels que dérivés d 'amines primaires et/ou secondaires et/ou tertiaires et/ou dérivés alkyliques et/ou aryliques et/ou polyamines et/ou alkylamminoglycines et/ou alkylamines tertiaires, en l'incorporation de dérivés de méthyle pyrrolidone, plus particulièrement et d'une manière non exhaustive, de polyvinyle pyrrolidone, à des concentrations minimum de 0,001 7. jusqu 'à des concentrations maximum permettant de fabriquer et formuler des produits sous forme de pastilles, cachets solides ou de poudre.On the one hand, the present invention consists in the procedure for the formulation of amine derivatives such as derivatives of primary and / or secondary and / or tertiary amines and / or alkyl and / or aryl derivatives and / or polyamines and / or alkylamminoglycines. and / or tertiary alkylamines, in the incorporation of methyl pyrrolidone derivatives, more particularly and in a non-exhaustive manner, polyvinyl pyrrolidone, at concentrations of at least 0.001%, up to maximum concentrations which make it possible to manufacture and formulate products in the form of pellets, solid tablets or powder.

La polyvinyle pyrrolidone est largement décrite dans les documentations et dictionnaires chimiques et plus particulièrement dans la gamme GAF USA sous les appellations FVF Kan et FVP X9O. Polyvinyl pyrrolidone is widely described in the literature and chemical dictionaries and more particularly in the GAF USA range under the names FVF Kan and FVP X9O.

La polyvinyle pyrrolidone a souvent été utilisée pour la mise en solution relativement stable de l'iode aqueux alcoolique. Elle est aussi utilisée pour la fabrication d'enveloppes consommables pharmaceutiques, de cachets micro-capsules permettant d'enfermer le composé actif médicamenteux
L'incorporation de la polyvinyle pyrrolidone dans une préparation de produits dérivés d'amines primaires et/ou secondaires et/ou tertiaires et/ou dérivés alkyliques et/ou aryliques et/ou polyamines et/ou alkylamminoglycines et/ou alkylamines tertiaires peut se réaliser par simple dissolution au cours de la préparation du mélange Une température de 40 a 450 facilite la dissolution du produit. Polyvinyl pyrrolidone has often been used for the relatively stable solution of aqueous alcoholic iodine. It is also used for the manufacture of pharmaceutical consumable envelopes, micro-capsule tablets for enclosing the active drug compound
The incorporation of the polyvinylpyrrolidone in a preparation of products derived from primary amines and / or secondary and / or tertiary and / or alkyl and / or aryl derivatives and / or polyamines and / or alkylamminoglycines and / or tertiary alkylamines can be realized by simple dissolution during the preparation of the mixture A temperature of 40 to 450 facilitates the dissolution of the product.

Une telle préparation, telle que décrite ci-dessus à titre non exhaustif, en comparaison d'une préparation similaire exempte du procédé de la présente invention, permettrait une comparaison rapide et facile de l'avantage du procédé.Such a preparation, as described above in a non-exhaustive manner, in comparison with a similar preparation free from the process of the present invention, would allow a quick and easy comparison of the advantage of the process.

FORMULE SELON LE PROCEDE

Figure img00030001
FORMULA ACCORDING TO THE PROCESS
Figure img00030001

<tb> 1 <SEP> 2 <SEP> 3 <SEP> 4 <SEP> 5 <SEP> 6 <SEP>
<tb> LONZABAC <SEP> 12 <SEP> 10 <SEP> X <SEP> 10 <SEP> % <SEP> ---- <SEP> ---- <SEP> 10 <SEP> % <SEP>
<tb> LONZABAC <SEP> 4 <SEP> ---- <SEP> ---- <SEP> 10 <SEP> % <SEP> 10 <SEP> % <SEP> ---- <SEP> 10 <SEP> % <SEP>
<tb> PVP <SEP> K30 <SEP> 5 <SEP> % <SEP> ---- <SEP> 3 <SEP> % <SEP> ---- <SEP> ---- <SEP> ---
<tb> PVP <SEP> K90 <SEP> ---- <SEP> 2 <SEP> % <SEP> ---- <SEP> 0,01 <SEP> % <SEP> ---- <SEP> ---- <SEP>
<tb> H20 <SEP> QSP <SEP>
<tb>
Nous introduirons dans 20 ml de chacune des formules, 1 goutte de glutaraldéhyde et nous constaterons
Solution N01 : changement de couleur (tendance rouge, marron) sans coagulation ni adhérence - Produit restant liquide et fluide
Solution N 2 : changement de couleur (tendance rouge, marron) sans coagulation ni adhérence - Produit restant liquide et fluide
Solution N03 : changement de couleur (tendance rouge, marron) sans coagulation ni adhérence - Produit restant liquide et fluide
Solution N04 : changement de couleur (tendance rouge, marron) sans coagulation ni adhérence - Produit restant liquide et fluide
Solution N05 :: prise en masse spongieuse immédiate ressemblant entre la mousse de polyuréthanne durant les premières heures et après plusieurs jours, ayant la consistance du chocolat (avec adhérences). <tb> 1 <SEP> 2 <SEP> 3 <SEP> 4 <SEP> 5 <SEP> 6 <SEP>
<tb> LONZABAC <SEP> 12 <SEP> 10 <SEP> X <SEP> 10 <SEP>% <SEP> ---- <SEP> ---- <SEP> 10 <SEP>% <SEP>
<tb> LONZABAC <SEP> 4 <SEP> ---- <SEP> ---- <SEP> 10 <SEP>% <SEP> 10 <SEP>% <SEP> ---- <SEP> 10 <SEP>%<SEP>
<tb> PVP <SEP> K30 <SEP> 5 <SEP>% <SEP> ---- <SEP> 3 <SEP>% <SEP> ---- <SEP> ---- <SEP> - -
<tb> PVP <SEP> K90 <SEP> ---- <SEP> 2 <SEP>% <SEP> ---- <SEP> 0.01 <SEP>% <SEP> ---- <SEP> ---- <SEP>
<tb> H20 <SEP> QSP <SEP>
<Tb>
We will introduce in 20 ml of each of the formulas, 1 drop of glutaraldehyde and we will find
Solution N01: color change (red, brown tendency) without coagulation or adhesion - Product remaining liquid and fluid
Solution N 2: change of color (red, brown tendency) without coagulation or adhesion - Product remaining liquid and fluid
Solution N03: color change (trend red, brown) without coagulation or adhesion - Product remaining liquid and fluid
Solution N04: color change (trend red, brown) without coagulation or adhesion - Product remaining liquid and fluid
Solution N05 :: taking immediate spongy mass resembling between the polyurethane foam during the first hours and after several days, having the consistency of chocolate (with adhesions).

Solution N 6 : prise en masse spongieuse immédiate ressemblant entre la mousse de polyuréthanne durant les premières heures et après plusieurs jours, ayant la consistance du chocolat (avec adhérences). Solution N 6: Immediate spongy massing resembling between the polyurethane foam during the first hours and after several days, having the consistency of chocolate (with adhesions).

D'autre part, la présente invention consiste dans la procédure de formulation de dérivés aldéhydiques et plus particulièrement et d'une manière non exhaustive, de glutaraldéhyde, dans un milieu solvant compatible dont l'eau par 1 'incorporation de dérivés de pyrrolidone et plus particulièrement et d'une manière non exhaustive de polyvinyle pyrrolidone de telle manière a ce qu'une telle préparation mise en contact avec des dérivés d'amines primaires et/ou secondaires et/ou tertiaires et/ou de dérivés alkyliques et/ou aryliques et/ou polyamines et/ou alkylamminoglycines et/ou alkylamines tertiaires ne forment pas une prise en masse des agglomérats, des adhérences. On the other hand, the present invention consists in the procedure for the formulation of aldehyde derivatives and more particularly and in a non-exhaustive manner, of glutaraldehyde, in a compatible solvent medium including water by the incorporation of pyrrolidone derivatives and more. particularly and in a non-exhaustive manner of polyvinyl pyrrolidone such that such a preparation is brought into contact with primary and / or secondary and / or tertiary amine derivatives and / or alkyl and / or aryl derivatives and and / or polyamines and / or alkylamminoglycines and / or tertiary alkylamines do not form a setting of agglomerates or adhesions.

On pourra procéder à l'introduction d'une certaine quantité de polyvinyle pyrrolidone variant de 0,001 % jusqu'à des concentrations maximum permettant de fabriquer et de formuler sous forme de pastilles, cachets, poudre, dans des préparations aldéhydiques dont des solutions de glutaraldéhyde et nous constaterons rapidement selon le test ci-dessous l'avantage de l'invention : :

Figure img00040001
It will be possible to introduce a quantity of polyvinyl pyrrolidone ranging from 0.001% up to maximum concentrations making it possible to manufacture and formulate in the form of pellets, tablets, powder, in aldehyde preparations including solutions of glutaraldehyde and we will quickly see according to the test below the advantage of the invention:
Figure img00040001

<tb> <SEP> 7 <SEP> 8 <SEP> 9
<tb> GLUTARALDEHYDE <SEP> 10 <SEP> X <SEP> 8 <SEP> X <SEP> 10 <SEP> X <SEP>
<tb> PVP <SEP> K30 <SEP> 1 <SEP> % <SEP> ---- <SEP> ---- <SEP>
<tb> PVP <SEP> K90 <SEP> ---- <SEP> 0,2 <SEP> % <SEP> ---
<tb> H20 <SEP> QSP
<tb>
Nous allons mettre en contact les solutions 7 / 8 / 9 avec des dérivés aminés par exemple et d'une maniere non exhaustive,
LONZABAC 12 à raison de 1 goutte pour 20 ml de la solution 7, de la solution 8, de la solution 9.<tb><SEP> 7 <SEP> 8 <SEP> 9
<tb> GLUTARALDEHYDE <SEP> 10 <SEP> X <SEP> 8 <SEP> X <SEP> 10 <SEP> X <SEP>
<tb> PVP <SEP> K30 <SEP> 1 <SEP>% <SEP> ---- <SEP> ---- <SEP>
<tb> PVP <SEP> K90 <SEP> ---- <SEP> 0.2 <SEP>% <SEP> ---
<tb> H20 <SEP> QSP
<Tb>
We will put the solutions 7/8/9 in contact with amino derivatives for example and in a non-exhaustive way,
LONZABAC 12 at a rate of 1 drop per 20 ml of solution 7, solution 8, solution 9.

Dans le cas de la solution 7 et 8, la solution changera de couleur mais restera fluide.In the case of solution 7 and 8, the solution will change color but remain fluid.

Dans le cas de la solution N09, prise en masse rapide à constater formant un agglomérat. In the case of the solution N09, fast setting to mass forming an agglomerate.

Claims (8)

REVENDICATIONS 1) Composition renfermant des dérivés aminés ou des dérivés aidéhydiques pouvant hêtre mis en contact avec des matiéres chimiques incompatibles sans formation de prise en masse d'agglomérats, d'adhérences et caractérisée en ce qu'elle contient au mois 0,001 X d'un dérive de pyrrolidone.1) Composition comprising amino derivatives or aidedic acid derivatives which can be brought into contact with incompatible chemical materials without formation of agglomerates, adhesions and characterized in that it contains at least 0.001 X of a drift pyrrolidone. 2) Composition selon l'une des quelconques revendications, caractérisée en ce que le dérivé aminé est un dérivé d'amine primaire et/ou secondaire etZou tertiaire et/ou dérive alkylique et/ou arylique et/ou polyamine et/ou alkylaminoglycine etZou alkylamine tertiaire.2) Composition according to any one of claims, characterized in that the amino derivative is a primary amine derivative and / or secondary and / or tertiary and / or alkyl derivative and / or aryl and / or polyamine and / or alkylaminoglycine and / or alkylamine tertiary. 3) Composition selon l'une des quelconques revendications caractérisée en ce que le dérive aminé est un diamino propyle lauryl amine.3) Composition according to any one of claims characterized in that the amine drift is a diamino propyl lauryl amine. 4) Composition selon l'une des quelconques revendications caractérisée en ce que les dérivés aldéhydiques sont du formaldéhyde ou glutaraldéhyde.4) Composition according to any one of claims characterized in that the aldehyde derivatives are formaldehyde or glutaraldehyde. 5) Compositìon selon l'une des quelconques revendiations caractérisée en ce que le dérivé de pyrrolidone est une polyvinyle pyrrolidone. 5) Composition according to any one of claims revendità © characterized in that the pyrrolidone derivative is a polyvinyl pyrrolidone. 6) Composition selon l'une des quelconques revendications caractérisée en ce que la concentration en polyvinyle pyrrolidone est au moins 0,001 % Jusqu' une concentration maximum permettant de fabriquer et de formuler sous forme de pastilles, cachets ou poudre.6) Composition according to any one of claims characterized in that the concentration of polyvinyl pyrrolidone is at least 0.001% up to a maximum concentration for manufacturing and formulating in the form of pellets, cachets or powder. 7) Composition selon l'une des quelconques revendications caractérisée en ce que la composition est réalisée sous forme liquide, gel, capsules, pastilles ou poudre.7) Composition according to any one of claims characterized in that the composition is carried out in liquid form, gel, capsules, pellets or powder. 8) Composition selon l'une des quelconques revendications caractérisée en ce que la composition est une composition à usage de désinfection. 8) Composition according to any one of claims characterized in that the composition is a composition for use disinfection.
FR9207714A 1992-06-24 1992-06-24 COMPOSITIONS CONTAINING AMINO DERIVATIVES OF ALDEHYDIC DERIVATIVES THAT CAN BE IN CONTACT WITH INCOMPATIBLE MATERIALS WITHOUT FORMATION OF AGGLOMERATES. Expired - Fee Related FR2692787B1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FR9207714A FR2692787B1 (en) 1992-06-24 1992-06-24 COMPOSITIONS CONTAINING AMINO DERIVATIVES OF ALDEHYDIC DERIVATIVES THAT CAN BE IN CONTACT WITH INCOMPATIBLE MATERIALS WITHOUT FORMATION OF AGGLOMERATES.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR9207714A FR2692787B1 (en) 1992-06-24 1992-06-24 COMPOSITIONS CONTAINING AMINO DERIVATIVES OF ALDEHYDIC DERIVATIVES THAT CAN BE IN CONTACT WITH INCOMPATIBLE MATERIALS WITHOUT FORMATION OF AGGLOMERATES.

Publications (2)

Publication Number Publication Date
FR2692787A1 true FR2692787A1 (en) 1993-12-31
FR2692787B1 FR2692787B1 (en) 1995-07-07

Family

ID=9431112

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9207714A Expired - Fee Related FR2692787B1 (en) 1992-06-24 1992-06-24 COMPOSITIONS CONTAINING AMINO DERIVATIVES OF ALDEHYDIC DERIVATIVES THAT CAN BE IN CONTACT WITH INCOMPATIBLE MATERIALS WITHOUT FORMATION OF AGGLOMERATES.

Country Status (1)

Country Link
FR (1) FR2692787B1 (en)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2349336A1 (en) * 1976-04-26 1977-11-25 Fellows Adrian DISINFECTANT AND STERILIZING PREPARATIONS BASED ON DI-ALDEHYDE
EP0212866A1 (en) * 1985-07-29 1987-03-04 Minnesota Mining And Manufacturing Company Nonirritating teat dip
EP0252310A2 (en) * 1986-06-12 1988-01-13 Merz & Co. GmbH & Co. Antimicrobial agents
EP0361033B1 (en) * 1988-08-19 1992-11-19 Bayer Ag Collagenous material coating

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2349336A1 (en) * 1976-04-26 1977-11-25 Fellows Adrian DISINFECTANT AND STERILIZING PREPARATIONS BASED ON DI-ALDEHYDE
EP0212866A1 (en) * 1985-07-29 1987-03-04 Minnesota Mining And Manufacturing Company Nonirritating teat dip
EP0252310A2 (en) * 1986-06-12 1988-01-13 Merz & Co. GmbH & Co. Antimicrobial agents
EP0361033B1 (en) * 1988-08-19 1992-11-19 Bayer Ag Collagenous material coating

Also Published As

Publication number Publication date
FR2692787B1 (en) 1995-07-07

Similar Documents

Publication Publication Date Title
EP0064967B1 (en) Process for producing submicroscopic particles, particles obtained in that way and pharmaceutical compositions containing them
CA2680433C (en) Novel composition based on cholest-4-ene-3-one oxime
EP0608207A1 (en) Nanocapsule containing pharmaceutical compositions
FR2542194A1 (en) PHARMACEUTICAL PREPARATIONS BASED ON RIFAMPICIN HAVING UNIFORM ELUTING PROPERTIES
FR2692787A1 (en) Disinfectant compsn. contg. amine and/or aldehyde - contg. pyrrolidone cpd., to prevent coagulation in presence of incompatible cpd.
WO2000035933A1 (en) Troxerutin with high trihydroxy-ethyl-rutin content and method for preparing same
EP0092287B2 (en) Acetylcysteine salts, their preparation and use
EP0653159B1 (en) Desinfecting composition
EP0827691A1 (en) Decontaminating and cleaning composition in powder form and process for obtaining it
FR3079413A1 (en) LIQUID COMPOSITION FOR LIMITING, REDUCING AND / OR TREATING DISORDERS ASSOCIATED WITH INTOXICATION OF THE HEAVY METAL ORGANISM.
FR2616068A1 (en) Method for stabilising the active principles of plant products and pharmaceutical compositions containing these stabilised active principles
JPS6112623A (en) Encephalinase inhibiting agent
JPS58128317A (en) Preventive of animal coccidioidis
EP0116182A1 (en) Process for the preparation of finely divided p-butoxyphenyl acethydroxamic acid
US332804A (en) Chaelbs l
JPS58128321A (en) Preventive of animal coccidiodis
FR2581311A1 (en) Pharmaceutical compositions for the treatment of colites and colopathies, based on thyme oil and cade essential oil.
FR2494993A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING 1- (2-3&#39;CARBOXYPROPIONYL OXYETHYL) -2-METHYL-5-NITROIMIDAZOLE OR ITS SALTS AS ACTIVE THERAPEUTIC AGENTS AGAINST DISEASES CAUSED BY ANAEROBIC GERM
JPH07145004A (en) Composition containing amine derivative or aldehyde derivative and pyrrolidone derivative and its application to sterilization or cleaning surgical equipment
EP0150186A1 (en) Composition having an improved pharmaceutical activity and utilisation thereof in veterinary medecine
KR950005869B1 (en) Therapeutic agent for gastritis
FR2589731A1 (en) PROCESS FOR THE PREPARATION OF (-) EBURNAMENINE-14- (15H) -ONE RESINATES
CN106674019A (en) Cinacalcet hydrochloride active pharmaceutical ingredient and preparation method thereof
FR2581068A1 (en) Inclusion complex of a phosphorus-containing organic calcium compound and of cyclodextrin, process for its preparation and its use for protecting plants
BE678166A (en)

Legal Events

Date Code Title Description
ST Notification of lapse